Hagop M. Kantarjian - Concepedia

Author

Hagop M. Kantarjian

The University of Texas MD Anderson Cancer Center

Also Known As

Hagop M. Kantarjian

Publications

367

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Anderson Hospital Breast Cancer Care

About

Hagop M. Kantarjian is an author at The University of Texas MD Anderson Cancer Center specializing in cancer research, oncology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	104
2	Cell Biology	1	1	51
3	Immunology	1	1	53
4	Pathology	1	1	53
5	Pharmacology	1	1	51

Hagop M. Kantarjian

Publications

365

Citations

H-Index

Page 1

	Year	Citations
Effects of low doses of recombinant human granulocyte‐macrophage colony stimulating factor (GM‐CSF) in patients with myelodysplastic syndromes Elihu H. Estey, Razelle Kurzrock, Moshe Talpaz, British Journal of Haematology	1991	76
Phase II study of low-dose continuous infusion homoharringtonine in refractory acute myelogenous leukemia Hagop M. Kantarjian, Michael J. Keating, Ronald S. Walters, Cancer	1989	54
Intensive chemotherapy induction followed by interferon-alpha maintenance in patients with Philadelphia chromosome-positive chronic myelogenous leukemia Hagop M. Kantarjian, Moshe Talpaz, Michael J. Keating, Cancer Hematological MalignancyMedicineIntensive Chemotherapy InductionMixed-phenotype Acute LeukemiaImmunology	1991	53
Mitoxantrone and high-dose cytosine arabinoside in refractory acute myelogenous leukemia Ronald S. Walters, Hagop M. Kantarjian, Michael J. Keating, Cancer Hematological MalignancySalvage ChemotherapyMedicineMixed-phenotype Acute LeukemiaMalignant Blood Disorder	1988	51
Mitoxantrone and high-dose cytosine arabinoside for the treatment of refractory acute lymphocytic leukemia Hagop M. Kantarjian, Ronald Walters, Michael J. Keating, Cancer	1990	51
The breakpoint cluster region site in patients with Philadelphia chromosome–positive chronic myelogenous leukemia. Clinical, laboratory, and prognostic correlations Claire F. Verschraegen, Hagop M. Kantarjian, Cherryl Hirsch-Ginsberg, Cancer	1995	33
Therapy of lymphoid and undifferentiated chronic myelogenous leukemia in blast crisis with continuous vincristine and adriamycin infusions plus high-dose decadron Ronald S. Walters, Hagop M. Kantarjian, Michael J. Keating, Cancer	1987	30
Comparison of Results of Salvage Therapy in Adult Acute Myelogenous Leukemia Michael J. Keating, Elihu H. Estey, Hagop M. Kantarjian, Acta Haematologica	1987	17

Page 1